229 related articles for article (PubMed ID: 21789719)
1. Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10.
Schelter F; Grandl M; Seubert B; Schaten S; Hauser S; Gerg M; Boccaccio C; Comoglio P; Krüger A
Clin Exp Metastasis; 2011 Dec; 28(8):793-802. PubMed ID: 21789719
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.
Kopitz C; Gerg M; Bandapalli OR; Ister D; Pennington CJ; Hauser S; Flechsig C; Krell HW; Antolovic D; Brew K; Nagase H; Stangl M; von Weyhern CW; Brücher BL; Brand K; Coussens LM; Edwards DR; Krüger A
Cancer Res; 2007 Sep; 67(18):8615-23. PubMed ID: 17875701
[TBL] [Abstract][Full Text] [Related]
3. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α.
Schelter F; Halbgewachs B; Bäumler P; Neu C; Görlach A; Schrötzlmair F; Krüger A
Clin Exp Metastasis; 2011 Feb; 28(2):91-9. PubMed ID: 21053058
[TBL] [Abstract][Full Text] [Related]
5. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
6. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism.
Bakken AM; Protack CD; Roztocil E; Nicholl SM; Davies MG
J Vasc Surg; 2009 May; 49(5):1296-303. PubMed ID: 19394555
[TBL] [Abstract][Full Text] [Related]
7. Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression.
Twito T; Chen Z; Khatri I; Wong K; Spaner D; Gorczynski R
Leuk Res; 2013 Jul; 37(7):816-21. PubMed ID: 23643150
[TBL] [Abstract][Full Text] [Related]
8. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
[TBL] [Abstract][Full Text] [Related]
9. ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices.
Kwak HI; Mendoza EA; Bayless KJ
Matrix Biol; 2009 Oct; 28(8):470-9. PubMed ID: 19666115
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
Doberstein K; Pfeilschifter J; Gutwein P
Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference.
Xu Q; Liu X; Chen W; Zhang Z
J Transl Med; 2010 Dec; 8():136. PubMed ID: 21171968
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive gene expression profiling and functional analysis of matrix metalloproteinases and TIMPs, and identification of ADAM-10 gene expression, in a corneal model of epithelial resurfacing.
Gordon GM; Austin JS; Sklar AL; Feuer WJ; LaGier AJ; Fini ME
J Cell Physiol; 2011 Jun; 226(6):1461-70. PubMed ID: 20625997
[TBL] [Abstract][Full Text] [Related]
13. c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.
Otte A; Rauprich F; von der Ohe J; Yang Y; Kommoss F; Feuerhake F; Hillemanns P; Hass R
Oncotarget; 2015 Oct; 6(31):31640-58. PubMed ID: 26436697
[TBL] [Abstract][Full Text] [Related]
14. ADAM10/17-dependent release of soluble c-Met correlates with hepatocellular damage.
Chalupský K; Kanchev I; Žbodáková O; Buryová H; Jiroušková M; Kořínek V; Gregor M; Sedláček R
Folia Biol (Praha); 2013; 59(2):76-86. PubMed ID: 23746173
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10.
Prox J; Willenbrock M; Weber S; Lehmann T; Schmidt-Arras D; Schwanbeck R; Saftig P; Schwake M
Cell Mol Life Sci; 2012 Sep; 69(17):2919-32. PubMed ID: 22446748
[TBL] [Abstract][Full Text] [Related]
16. ADAM-10 and -17 regulate endometriotic cell migration via concerted ligand and receptor shedding feedback on kinase signaling.
Miller MA; Meyer AS; Beste MT; Lasisi Z; Reddy S; Jeng KW; Chen CH; Han J; Isaacson K; Griffith LG; Lauffenburger DA
Proc Natl Acad Sci U S A; 2013 May; 110(22):E2074-83. PubMed ID: 23674691
[TBL] [Abstract][Full Text] [Related]
17. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.
Karan D; Lin FC; Bryan M; Ringel J; Moniaux N; Lin MF; Batra SK
Int J Oncol; 2003 Nov; 23(5):1365-71. PubMed ID: 14532978
[TBL] [Abstract][Full Text] [Related]
18. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
[TBL] [Abstract][Full Text] [Related]
19. A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor.
Schelter F; Kobuch J; Moss ML; Becherer JD; Comoglio PM; Boccaccio C; Krüger A
J Biol Chem; 2010 Aug; 285(34):26335-40. PubMed ID: 20554517
[TBL] [Abstract][Full Text] [Related]
20. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.
Amour A; Knight CG; Webster A; Slocombe PM; Stephens PE; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 2000 May; 473(3):275-9. PubMed ID: 10818225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
